30-Apr-23 | 24-Apr-22 | 25-Apr-21 | 26-Apr-20 | 28-Apr-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Asia | 77.80 | 1% | 44.50 | 1% | 43.70 | 1% | 48.90 | 1% | n/a | n/a |
Europe | 1,024.60 | 18% | 823.00 | 17% | 646.20 | 18% | 722.30 | 18% | n/a | n/a |
Non UK | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 937.70 | 25% |
UK | 4,309.40 | 78% | 3,714.80 | 77% | 2,721.70 | 75% | 2,951.00 | 75% | 2,764.20 | 75% |
USA | 136.40 | 2% | 223.00 | 5% | 213.70 | 6% | 235.20 | 6% | n/a | n/a |
Unanalysed | (106.90) | n/a | (132.40) | n/a | (118.00) | n/a | n/a | n/a | n/a | n/a |
Total | 5,441.30 | 100% | 4,672.90 | 100% | 3,507.30 | 100% | 3,957.40 | 100% | 3,701.90 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 634.30 | 100% | 306.70 | 100% | (1.20) | 100% | 143.50 | 100% | 179.20 | 100% |
Total | 634.30 | 100% | 306.70 | 100% | (1.20) | 100% | 143.50 | 100% | 179.20 | 100% |
30-Apr-23 | 24-Apr-22 | 25-Apr-21 | 26-Apr-20 | 28-Apr-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Eliminations | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | (10.50) | n/a |
Retail | 5,376.90 | 97% | 4,637.20 | 97% | 3,472.00 | 96% | 3,797.20 | 96% | 3,538.40 | n/a |
Unanalysed | (123.90) | n/a | (132.40) | n/a | (118.00) | n/a | n/a | n/a | n/a | n/a |
Wholesale & Licensing | 188.30 | 3% | 168.10 | 3% | 153.30 | 4% | 160.20 | 4% | 174.00 | n/a |
Total | 5,441.30 | 100% | 4,672.90 | 100% | 3,507.30 | 100% | 3,957.40 | 100% | 3,701.90 | n/a |
Profit Before Tax | ||||||||||
Retail | n/a | n/a | n/a | n/a | (35.80) | 99% | 161.00 | 94% | n/a | n/a |
Unanalysed | 634.30 | n/a | 306.70 | n/a | 35.00 | n/a | (28.40) | n/a | 179.20 | n/a |
Wholesale & Licensing | n/a | n/a | n/a | n/a | (0.40) | 1% | 10.90 | 6% | n/a | n/a |
Total | 634.30 | n/a | 306.70 | n/a | (1.20) | 100% | 143.50 | 100% | 179.20 | n/a |
You are here: research